Link copied
Lilly Approves $15 Billion in Share Buybacks, Raises Dividend
stock :: 2024-12-10 :: source - bloomberg
By John Lauerman
(Bloomberg) -- Eli Lilly & Co. approved a program to buy back as much as $15 billion of its own shares amid rapid growth fueled in part by the blockbuster weight-loss drug Zepbound.
Most Read from Bloomberg
A Chicago Skyscraper Cements the Legacy of a Visionary Postmodern Architect
Cloud Computing Tax Threatens Chicago’s Silicon Valley Ambitions
NYC’s Run-Down Bus Terminal Gets Approval for $10 Billion Revamp
Kansas City Looks Back on its Long, Costly Ride With Microtransit
The company also raised its quarterly dividend 15%, according to a statement Monday. The shares rose as much as 1.3% in late trading after the US markets closed.
The share repurchases may be made from time to time at management’s discretion, Lilly said.
Most Read from Bloomberg Businessweek
This week top market trends.
-
Jeff Bezos Backs AI Chipmaker Vying With Nvidia at $2.6 Billion Value
2024-12-02 :: deals & business :: bloomberg -
Amazon holder group urges firm to invest big in bitcoin
2024-12-13 :: crypto :: thestreet -
Bitcoin is 'far from being a bubble,' Pantera's Morehead says
2024-11-26 :: crypto :: bloomberg -
Sam Altman-backed Oklo signs power agreement with data center operator: share surges
2024-12-18 :: stock :: reuters -
UPS to Pay $45 Million SEC Penalty Over Improper Valuation
2024-11-23 :: stock :: bloomberg
Recent global market news
-
Micron shares tumble as quarterly forecast signals sluggish consumer demand
2024-12-19 :: :: reuters
